TP53 and intrahepatic cholangiocarcinoma: Within our group of canonical driver mutations, we found that (with the exception of KRAS and TP53) there is a consistent and high level of mutual exclusivity between canonical driver genes, suggesting that the recurrent mutations found across studies are not interdependent for ICC initiation and growth (Fig. 1E).